Search Results for: newconnect

Bioceltix will raise funds for biological drug development

Bioceltix will raise funds for biological drug development

Bioceltix, one of the new hopes in the Polish biotechnology arena, has published an information memorandum stating that it plans to raise up to PLN 7.4m through a public offering of up to 360,000 new issue shares. In addition, the Wroclaw-based company plans to debut on the NewConnect stock exchange in the second quarter of…

Nestmedic online store launches
| |

Nestmedic online store launches

In early December 2020, Nestmedic, a company operating on the telemedicine and healthcare market, launched its online store. Through the store one can, among others, rent a Pregnabit device for a fee. Pregnabit to be purchased at online store Nestmedic, a company operating on the telemedicine market in Poland, launched an online store at the…

Michal Wasilewski for PMR: Health-oriented supplementation becomes one of the elements of everyday life

Michal Wasilewski for PMR: Health-oriented supplementation becomes one of the elements of everyday life

Closed fitness clubs, overall reduction of physical activity and social isolation significantly affect the performance of companies operating in the area of products used to achieve their training goals. Michal Wasilewski, owner and founder of the 7Nutrition brand, talks to PMR about how the COVID-19 pandemic affects the market of nutrients and dietary supplements for…

Former CEO of AstraZeneca on the Board of Genomtec
|

Former CEO of AstraZeneca on the Board of Genomtec

Jarek Oleszczuk was appointed to the board of the Polish start-up Genomtec. As Chief Business Officer (CBO) he will be responsible for further development and implementation of the business strategy. Will Oleszczuk’s experience gained in managing large pharmaceutical corporations help Genomtec to grow faster? AstraZeneca, AbbVie, Abbott, Novartis… Jarek Oleszczuk has many years of experience…

Up to EUR 10m loan to Scope Fluidics from the EIB
|

Up to EUR 10m loan to Scope Fluidics from the EIB

The EIB will support the financing of the development of innovative methods for the detection of pathogens in the field of laboratory diagnostics that cause infectious diseases, including COVID-19. Under the agreement it will provide a loan to Scope Fluidics. Details of the agreement with the EIB The concluded agreement is the first such project…

New company on the WSE?

New company on the WSE?

Inno-Gene SA, a company operating in the area of medical diagnostics, has announced the commencement of activities aimed at transferring shares from NewConnect to the WSE main market. Currently, the issuer’s management board has started talks with brokerage houses and law firms which are to carry out the whole process. Purpose of the transition to…

Dent-a-Medical with bankruptcy petition
| |

Dent-a-Medical with bankruptcy petition

The Management Board of Dent-a-Medical, a company listed on NewConnect, filed a bankruptcy petition under the Restructuring Law on 30 January this year. The company stated that this is due to the situation that the monetary liabilities exceed the value of its assets. This state lasts for over 24 months. Opening of the restructuring procedure…

Big plans for Invention Med
|

Big plans for Invention Med

Invention Med, a Polish technology company specializing in virtual and augmented reality solutions, has ambitious development plans for the coming years. The company plans to build, among others, the Centre for Innovative Medical Simulations in Bydgoszcz. It also wants to develop a virtual syringe. Additionally, Invention Med hopes to be switched to the Warsaw Stock…